Although the principles of appropriate formulation of oral rehydration solution have been extensively studied, controversies still remain regarding the electrolyte composition.' 2 The current World Health Organisation (WHO) oral rehydration solution, which contains bicarbonate, has some practical disadvantages when packed and stored under climatic conditions of high humidity and temperature. In these circumstances bicarbonate reacts with glucose or sucrose resulting in a brownish discolouration which is less acceptable to patients. The potassium concentration (20 mmol/1) in WHO solution is not adequate for the treatment of undernourished children with depleted total body potassium who may lose more than 30 mmol potassiumll of stool while suffering diarrhoea due to cholera, Escherichia coli, or rotavirus infection.3 Our previous study has shown that sodium citrate is as effective as sodium bicarbonate in correcting acidosis in diarrhoea. 4 Tripotassium citrate monohydrate is a stable crystalline salt that will not cause discolouration so readily when mixed with glucose or sucrose and stored in packets under conditions of high humidity. Thus an oral rehydration solution containing 10 mmol/l (3-24 g) of tripotassium citrate/l will provide both adequate alkali and a higher concentration of potassium than the WHO solution.
We Clinical characteristics of the children at the time of hospital admission in relation to age, sex, duration of diarrhoea, body weight, nutritional status, and haematocrit were not different between the groups. About 50% of the children were admitted with signs of moderate dehydration and acidosis as determined by serum bicarbonate (less than 15 mmol/l). All 48 (100%) children receiving the WHO solution and 44 of 46 (96%) children receiving potassium citrate solution were successfully rehydrated and maintained their hydration status well until diarrhoea stopped. The two in whom oral treatment failed (cholera patients) were withdrawn from the study. Although they drank sufficient rehydration solution they remained dehydrated and failed to gain body weight due to persistent vomiting and heavy purging (greater than 10 ml/kg per hour). They were subsequently treated with intravenous fluid. Frequency of vomiting in patients receiving (Table 2) . Serum sodium and chloride, stool potassium contents at 0, 24, and 48 hours showed no significant differences between groups. All patients passed urine satisfactorily within 12 hours. Hypokalaemic children conserved potassium significantly better than normokalaemic children ( Table 2) .
The aetiological agents identified in the patients were V cholerae (2), Shigella sp (1), ETEC (8) , and rotavirus (12) in the potassium citrate group, and V cholerae (3), Shigella sp (1), ETEC (8) , and rotavirus (12) in the WHO group.
Discussion
This study shows that potassium citrate salt can be used in place of sodium bicarbonate and potassium chloride in oral rehydration solution, thereby reducing the number of ingredients from four to three. This study further confirms the findings of Nalin and co-workers, that hypokalaemia can be treated satisfactorily by using a higher concentration of potassium without any danger of hyperkalaemia.°Re-latively fewer patients remained hypokalaemic after treatment with a higher concentration of potassium. This suggests that a higher concentration of potassium is necessary to treat hypokalaemia and associated diarrhoea, particularly in developing countries where malnutrition with associated total body potassium depletion is a major health problem. Hypokalaemic children excrete less potassium in urine as most of the potassium is conserved by the body to resolve the hypokalaemia.
The reason for delayed correction of biochemical acidosis in patients receiving potassium citrate solution is not fully understood and needs further investigations. Delayed resolution of acidosis may, however, have little practical importance. 
